Evaluation of hypoxia pathway genes and serum parameters in new coronavirus pneumonia (COVID-19)
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- How to tackle single target gene positive results of SARS‐CoV‐2 real‐time PCR: A cross‐sectional studyHealth Science Reports, 2023
- Hypoxia-Inducible Factor 1α and Its Role in Lung Injury: Adaptive or MaladaptiveInflammation, 2023
- Human Coronavirus Infections—Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and SARS-CoV-22022
- HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19Signal Transduction and Targeted Therapy, 2021
- Altered Regulation of HIF-1α in Naive- and Drug-Resistant EGFR-Mutant NSCLC: Implications for a Vascular Endothelial Growth Factor-Dependent PhenotypeJournal of Thoracic Oncology, 2020
- The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the futureMicrobes and Infection, 2020
- Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancerProceedings of the National Academy of Sciences, 2007
- NF-κB plays a key role in hypoxia-inducible factor-1–regulated erythropoietin gene expressionExperimental Hematology, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- The Regulation of Anoikis: MEKK-1 Activation Requires Cleavage by CaspasesCell, 1997